Analyst forecasts for Eli Lilly and balance sheet: Earnings expectations of $2.47 per share

Analyst forecasts for Eli Lilly and balance sheet: Earnings expectations of $2.47 per share

Eli Lilly's quarterly earnings are expected to be released on April 30, 2024. Experts forecast that the company will report earnings per share averaging $2.47 for the quarter ended March 31, 2024. Compared to the previous year, in which EPS of USD 1.62 per share was generated, there is a potential increase.

Estimates from 15 analysts suggest that revenue for the most recent quarter will come in at $8.92 billion, on average. This would represent an increase of 28.09 percent compared to the previous quarter, where revenue was $6.96 billion. For the current fiscal year, 23 analysts on average expect earnings per share of USD 12.50, whereas only USD 5.82 were reported in the previous year. In terms of total revenue for the current fiscal year, 23 analysts on average estimate that Eli Lilly will generate a total of $41.46 billion, compared to $34.12 billion last year.

These estimates and forecasts reflect analysts' confidence in Eli Lilly's performance and potential. Investors and market watchers will be waiting eagerly to see whether the company will meet, exceed or disappoint expectations. The publication of the quarterly results is therefore awaited with great interest.